摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-Anhydro-1-deoxy-1-(cycloheptylamino)-D-mannitol | 1038821-06-5

中文名称
——
中文别名
——
英文名称
2,5-Anhydro-1-deoxy-1-(cycloheptylamino)-D-mannitol
英文别名
(2R,3S,4S,5R)-2-[(cycloheptylamino)methyl]-5-(hydroxymethyl)oxolane-3,4-diol
2,5-Anhydro-1-deoxy-1-(cycloheptylamino)-D-mannitol化学式
CAS
1038821-06-5
化学式
C13H25NO4
mdl
——
分子量
259.346
InChiKey
HWUQUHIAKZYZES-FDYHWXHSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    82
  • 氢给体数:
    4
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    2,5-Anhydro-1-deoxy-1-(cycloheptylamino)-D-mannitol二碳酸二叔丁酯4-二甲氨基吡啶 作用下, 以 1,4-二氧六环乙腈 为溶剂, 反应 2.0h, 以57%的产率得到2,5-anhydro-1-deoxy-1-[(tert-butoxycarbonyl)(cycloheptyl)amino]-D-mannitol
    参考文献:
    名称:
    Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis
    摘要:
    The glycolytic pathway has been considered a potential drug target against the parasitic protozoan species of Trypanosoma and Leishmania. We report the design and the synthesis of inhibitors targeted against Trypanosoma brucei phosphofructokinase (PFK) and Leishmania mexicana pyruvate kinase (PyK). Stepwise library synthesis and inhibitor design from a rational starting point identified furanose sugar amino amides as a novel class of inhibitors for both enzymes with IC(50) values of 23 mu M and 26 mu M against PFK and PyK, respectively. Trypanocidal activity also showed potency in the low micromolar range and confirms these inhibitors as promising candidates for the development towards the design of anti-trypanosomal drugs. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.03.045
  • 作为产物:
    描述:
    盐酸 、 sodium cyanoborohydride 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以66 mg的产率得到2,5-Anhydro-1-deoxy-1-(cycloheptylamino)-D-mannitol
    参考文献:
    名称:
    Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis
    摘要:
    The glycolytic pathway has been considered a potential drug target against the parasitic protozoan species of Trypanosoma and Leishmania. We report the design and the synthesis of inhibitors targeted against Trypanosoma brucei phosphofructokinase (PFK) and Leishmania mexicana pyruvate kinase (PyK). Stepwise library synthesis and inhibitor design from a rational starting point identified furanose sugar amino amides as a novel class of inhibitors for both enzymes with IC(50) values of 23 mu M and 26 mu M against PFK and PyK, respectively. Trypanocidal activity also showed potency in the low micromolar range and confirms these inhibitors as promising candidates for the development towards the design of anti-trypanosomal drugs. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.03.045
点击查看最新优质反应信息

文献信息

  • Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis
    作者:Matthew W. Nowicki、Lindsay B. Tulloch、Liam Worralll、Iain W. McNae、Véronique Hannaert、Paul A.M. Michels、Linda A. Fothergill-Gilmore、Malcolm D. Walkinshaw、Nicholas J. Turner
    DOI:10.1016/j.bmc.2008.03.045
    日期:2008.5
    The glycolytic pathway has been considered a potential drug target against the parasitic protozoan species of Trypanosoma and Leishmania. We report the design and the synthesis of inhibitors targeted against Trypanosoma brucei phosphofructokinase (PFK) and Leishmania mexicana pyruvate kinase (PyK). Stepwise library synthesis and inhibitor design from a rational starting point identified furanose sugar amino amides as a novel class of inhibitors for both enzymes with IC(50) values of 23 mu M and 26 mu M against PFK and PyK, respectively. Trypanocidal activity also showed potency in the low micromolar range and confirms these inhibitors as promising candidates for the development towards the design of anti-trypanosomal drugs. (c) 2008 Elsevier Ltd. All rights reserved.
查看更多